PT  - JOURNAL ARTICLE
AU  - Cenk Aypak
AU  - Özlem Türedi
AU  - Nisa Solmaz
AU  - Hülya Yıkılkan
AU  - Süleyman Görpelioğlu
TI  - A Rare Adverse Effect Of Montelukast Treatment: Ecchymosis
AID  - 10.4187/respcare.02298
DP  - 2013 Jan 15
TA  - Respiratory Care
PG  - respcare.02298
4099  - http://rc.rcjournal.com/content/early/2013/01/15/respcare.02298.short
4100  - http://rc.rcjournal.com/content/early/2013/01/15/respcare.02298.full
AB  - Montelukast is a leukotriene receptor antagonist that has been found to be effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman, with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients, treatment with montelukast should be discontinued.